HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016–2018

References

• Adam, B. D. (1995). The rise of a gay and lesbian movement. Twayne Pub.
   Google Scholar
• Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapia, M., Montoya-Herrera, O., Veloso, V. G., Mayer, K. H., Chariyalertsak, S., Schechter, M., Bekker, L.-G., Kallas, E. G., Grant, R. M., & For the iPrEx Study Team (2012). Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine, 4(151), 151ra125. https://doi.org/10.1126/scitranslmed.3004006
   PubMed Web of Science ®Google Scholar
• Astemborski, J., Vlahov, D., Warren, D., Solomon, L., & Nelson, K. E. (1994). The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal of Public Health, 84(3), 382–387. https://doi.org/10.2105/ajph.84.3.382
   PubMed Web of Science ®Google Scholar
• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kakia, A., Odoyo, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. https://doi.org/10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Bazzi, A. R., Biancarelli, D. L., Childs, E., Drainoni, M.-L., Edeza, A., Salhaney, P., Mimiaga, M. J., & Biello, K. B. (2018). Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care and STDS, 32(12), 529–537. https://doi.org/10.1089/apc.2018.0126
   PubMed Web of Science ®Google Scholar
• Beymer, M. R., DeVost, M. A., Weiss, R. E., Dierst-Davies, R., Shover, C. L., Landovitz, R. J., Beniasians, C., Talan, A. J., Flynn, R. P., Krysiak, R., McLaughlin, K., & Bolan, R. K. (2018). Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California. Sexually Transmitted Infections, 94(6), 457–462. https://doi.org/10.1136/sextrans-2017-053377
   PubMed Web of Science ®Google Scholar
• Biello, K. B., Bazzi, A. R., Mimiaga, M. J., Biancarelli, D. L., Edeza, A., Salhaney, P., Childs, E., & Drainoni, M. L. (2018). Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduction Journal, 15(1), 55. https://doi.org/10.1186/s12954-018-0263-5
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Gee, L., Lorvick, J., Moore, L., Seal, K., & Edlin, B. R. (2001). Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. JAIDS Journal of Acquired Immune Deficiency Syndromes, 28(3), 264–269.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., & Watters, J. K. (1995). Multimethod research from targeted sampling to HIV risk environments. Qualitative Methods in Drug Abuse and HIV Research, 212, 212–230.
   Google Scholar
• Brooks, R. A., Nieto, O., Landrian, A., Fehrenbacher, A., & Cabral, A. (2019). Experiences of Pre-Exposure Prophylaxis (PrEP)–Related Stigma among Black MSM PrEP Users in Los Angeles. Journal of Urban Health, 1–13.
   Web of Science ®Google Scholar
• Brown, T. N. (2003). Critical race theory speaks to the sociology of mental health: Mental health problems produced by racial stratification. Journal of Health and Social Behavior, 44(3), 292–301. https://doi.org/10.2307/1519780
   PubMed Web of Science ®Google Scholar
• Buttram, M. E., & Kurtz, S. P. (2019). Representations of pre-exposure prophylaxis, informal antiretroviral medication use for HIV prevention, and diversion on geosocial networking apps among men who have sex with men. AIDS and Behavior, 23(7), 1790–1796. https://doi.org/10.1007/s10461-018-2281-4
   PubMed Web of Science ®Google Scholar
• Cagle, H., Fisher, D., Senter, T., Thurmond, R., & Kastar, A. (2002). Classifying skin lesions of injection drug users: A method for corroborating disease risk. DHHS Pub. No.(SMA) 02.
   Google Scholar
• Centers for Disease Control & Prevention. (2014). US Public Health Service Preexposure prophylaxis for the prevention of HIV infection in the United States-2014. A clinical practice guideline. https://www.cdc/hiv/guidelines/index.html
   Google Scholar
• Centers for Disease Control & Prevention. (2018). Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: A clinical practice guideline. CDC.
   Google Scholar
• Chen, Y.-H., Guigayoma, J., McFarland, W., Snowden, J. M., & Raymond, H. F. (2018). Increases in pre-exposure prophylaxis use and decreases in condom use: Behavioral patterns among HIV-negative San Francisco men who have sex with men, 2004–2017. AIDS and Behavior, 23(7), 1–5.
   Web of Science ®Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., & Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• Chou, R., Evans, C., Hoverman, A., Sun, C., Dana, T., Bougatsos, C., Grusing, S., & Korthuis, P. T. (2019). Preexposure prophylaxis for the prevention of HIV infection: Evidence report and systematic review for the US preventive services task force. JAMA, 321(22), 2214–2230. https://doi.org/10.1001/jama.2019.2591
   PubMed Web of Science ®Google Scholar
• Cranston, K., Alpren, C., John, B., Dawson, E., Roosevelt, K., Burrage, A., Bryant, J., Switzer, W. M., Breen, C., Peters, P. J., Stiles, T., Murray, A., Fukuda, H. D., Adih, W., Goldman, L., Panneer, N., Callis, B., Campbell, E. M., Randall, L., … DeMaria, A. (2019). Notes from the field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015-2018. MMWR Morbidity and Mortality Weekly Report, 68(10), 253–254. https://doi.org/10.15585/mmwr.mm6810a6
   PubMed Web of Science ®Google Scholar
• Du Bois, W. E. B., & Eaton, I. (1899). The Philadelphia Negro: A social study. Published for the University.
   Google Scholar
• Edelman, E. J., Moore, B. A., Calabrese, S. K., Berkenblit, G., Cunningham, C., Patel, V., Phillips, K., Tetrault, J. M., Shah, M., Fiellin, D. A., & Blackstock, O. (2017). Primary care physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS and Behavior, 21, 1025–1033.
   PubMed Web of Science ®Google Scholar
• Eisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012). Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PLoS One, 7(1), e28238. https://doi.org/10.1371/journal.pone.0028238
   PubMed Web of Science ®Google Scholar
• Evans, M. E., Labuda, S. M., Hogan, V., Agnew-Brune, C., Armstrong, J., Periasamy Karuppiah, A. B., Blankinship, D., Buchacz, K., Burton, K., Cibrik, S., Hoffman, W., Kirk, N., Lee, C., McGraw, D., Bañez Ocfemia, M. C., Panneer, N., Reynolds, P., Rose, B., Salmon, M., … Mark-Carew, M. (2018). Notes from the field: HIV Infection investigation in a rural area - West Virginia, 2017. MMWR Morbidity and Mortality Weekly Report, 67(8), 257–258. https://doi.org/10.15585/mmwr.mm6708a6
   PubMed Web of Science ®Google Scholar
• Franks, J., Hirsch-Moverman, Y., Loquere, A. S., Amico, K. R., Grant, R. M., Dye, B. J., Rivera, Y., Gamboa, R., & Mannheimer, S. B. (2018). Sex, PrEP, and stigma: Experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT study. AIDS and Behavior, 22(4), 1139–1149. https://doi.org/10.1007/s10461-017-1964-6
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Ompad, D. C., Maslow, C., Young, R., Case, P., Hudson, S. M., Diaz, T., Morse, E., Bailey, S., Des Jarlais, D. C., Perlis, T., Hollibaugh, A., & Garfein, R. S. (2003). HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. American Journal of Public Health, 93(6), 902–906. https://doi.org/10.2105/AJPH.93.6.902
   PubMed Web of Science ®Google Scholar
• Gerstel, N., Bogard, C. J., McConnell, J. J., & Schwartz, M. (1996). The therapeutic incarceration of homeless families. Social Service Review, 70(4), 543–572. https://doi.org/10.1086/604215
   Web of Science ®Google Scholar
• Goedel, W. C., Halkitis, P. N., Greene, R. E., & Duncan, D. T. (2016). Correlates of awareness of and willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS and Behavior, 20(7), 1435–1442. https://doi.org/10.1007/s10461-016-1353-6
   PubMed Web of Science ®Google Scholar
• Golden, M. R., Lechtenberg, R., Glick, S. N., Dombrowski, J., Duchin, J., Reuer, J. R., Dhanireddy, S., Neme, S., & Buskin, S. E. (2019). Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018. MMWR Morbidity and Mortality Weekly Report, 68(15), 344–349. https://doi.org/10.15585/mmwr.mm6815a2
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., Montoya-Herrera, O., Fernández, T., Veloso, V. G., Buchbinder, S. P., Chariyalertsak, S., Schechter, M., Bekker, L.-G., Mayer, K. H., Kallás, E. G., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. https://doi.org/10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Hill, M. J., Holt, M., Hanscom, B., Wang, Z., Cardenas-Turanzas, M., & Latkin, C. (2018). Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 study. Drug and Alcohol Dependence, 183, 267–274. https://doi.org/10.1016/j.drugalcdep.2017.11.018
   PubMed Web of Science ®Google Scholar
• Hood, J. E., Buskin, S. E., Dombrowski, J. C., Kern, D. A., Barash, E. A., Katz, D. A., & Golden, M. R. (2016). Dramatic increase in preexposure prophylaxis use among MSM in Washington state. AIDS (London, England), 30(3), 515–519. https://doi.org/10.1097/QAD.0000000000000937
   PubMed Web of Science ®Google Scholar
• Jenness, S. M., Kobrak, P., Wendel, T., Neaigus, A., Murrill, C. S., & Hagan, H. (2011). Patterns of exchange sex and HIV infection in high-risk heterosexual men and women. Save Reference, 88(2), 329–341.
   Google Scholar
• Jenness, S. M., Weiss, K. M., Goodreau, S. M., Gift, T., Chesson, H., Hoover, K. W., Smith, D. K., Liu, A. Y., Sullivan, P. S., & Rosenberg, E. S. (2017). Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: A modeling study. Clinical Infectious Diseases, 65(5), 712–718. https://doi.org/10.1093/cid/cix439
   PubMed Web of Science ®Google Scholar
• Jo, Y., Bartholomew, T. S., Doblecki-Lewis, S., Rodriguez, A., Forrest, D. W., Tomita-Barber, J., Oves, J., & Tookes, H. E. (2020). Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida. PLoS One, 15(4), e0231424. https://doi.org/10.1371/journal.pone.0231424
   PubMed Web of Science ®Google Scholar
• Jordan, A. E., Des Jarlais, D. C., Arasteh, K., McKnight, C., Nash, D., & Perlman, D. C. (2015). Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug Alcohol Depend, 152, 194–200. https://doi.org/10.1016/j.drugalcdep.2015.03.039
   PubMed Web of Science ®Google Scholar
• Kral, A. H., Bluthenthal, R. N., Erringer, E. A., Lorvick, J., & Edlin, B. R. (1999). Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction, 94(5), 675–683. https://doi.org/10.1046/j.1360-0443.1999.9456755.x
   PubMed Web of Science ®Google Scholar
• Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. The Lancet, 357(9266), 1397–1401. https://doi.org/10.1016/S0140-6736(00)04562-1
   PubMed Web of Science ®Google Scholar
• Kral, A. H., Malekinejad, M., Vaudrey, J., Martinez, A. N., Lorvick, J., McFarland, W., & Raymond, H. F. (2010). Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. Journal of Urban Health, 87(5), 839–850. https://doi.org/10.1007/s11524-010-9486-9
   PubMed Web of Science ®Google Scholar
• Kuo, I., Olsen, H., Patrick, R., Phillips, G., Magnus, M., Opoku, J., Rawls, A., Peterson, J., Hamilton, F., Kharfen, M., & Greenberg, A. (2016). Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug and Alcohol Dependence, 164, 8–13. https://doi.org/10.1016/j.drugalcdep.2016.02.044
   PubMed Web of Science ®Google Scholar
• Lamb, S., Kral, A. H., Dominguez-Gonzalez, K., Wenger, L. D., & Bluthenthal, R. N. (2018). Peer-to-peer injection: Demographic, drug use, and injection-related risk factors. The International Journal on Drug Policy, 61, 44–51. https://doi.org/10.1016/j.drugpo.2018.07.001
   PubMed Web of Science ®Google Scholar
• Lee, C. T., Winquist, A., Wiewel, E. W., Braunstein, S., Jordan, H. T., Gould, L. H., Gwynn, R. C., & Lim, S. (2018). Long-term supportive housing is associated with decreased risk for new HIV diagnoses among a large cohort of homeless persons in New York City. AIDS and Behavior, 22(9), 3083–3090. https://doi.org/10.1007/s10461-018-2138-x
   PubMed Web of Science ®Google Scholar
• Martin, M., Vanichseni, S., Suntharasamai, P., Sangkum, U., Mock, P. A., Chaipung, B., Worrajittanon, D., Leethochawalit, M., Chiamwongpaet, S., Kittimunkong, S., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Holtz, T. H., Samandari, T., & Choopanya, K. (2017). Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: An observational, open-label extension of the Bangkok Tenofovir Study. The Lancet HIV, 4(2), e59–e66. https://doi.org/10.1016/S2352-3018(16)30207-7
   PubMed Web of Science ®Google Scholar
• Maslow, C. B., Friedman, S. R., Perlis, T. E., Rockwell, R., & Des Jarlais, D. C. (2002). Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. American Journal of Public Health, 92(3), 382–384. https://doi.org/10.2105/ajph.92.3.382
   PubMed Web of Science ®Google Scholar
• McFarland, W., Lin, J., Santos, G.-M., Arayasirikul, S., Raymond, H. F., & Wilson, E. (2019). Low PrEP awareness and use among people who inject drugs, San Francisco. AIDS and Behavior, 2018, 1–4.
   Google Scholar
• Morris, M. D., Shiboski, S., Bruneau, J., Hahn, J. A., Hellard, M., Prins, M., Cox, A. L., Dore, G., Grebely, J., Kim, A. Y., Lauer, G. M., Lloyd, A., Rice, T., Shoukry, N., Maher, L., Page, K., & International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3). (2017). Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: The InC3 collaboration. Clinical Infectious Diseases, 64(7), 860–869. https://doi.org/10.1093/cid/ciw869
   PubMed Web of Science ®Google Scholar
• Muncan, B., Walters, S. M., Ezell, J., & Ompad, D. C. (2020). They look at us like junkies”: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal, 17(1), 1–9. https://doi.org/10.1186/s12954-020-00399-8
   PubMed Web of Science ®Google Scholar
• Neaigus, A., Reilly, K. H., Jenness, S. M., Hagan, H., Wendel, T., & Gelpi-Acosta, C. (2013). Dual HIV risk: Receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City. AIDS and Behavior, 17(7), 2501–2509. https://doi.org/10.1007/s10461-013-0496-y
   PubMed Web of Science ®Google Scholar
• Nguyen, V.-K., Greenwald, Z. R., Trottier, H., Cadieux, M., Goyette, A., Beauchemin, M., Charest, L., Longpré, D., Lavoie, S., Tossa, H. G., & Thomas, R. (2017). Incidence of sexually transmitted infections before and after pre-exposure prophylaxis for HIV: A cohort study. AIDS, 32, 523–530. https://doi.org/10.1097/QAD.0000000000001718
   Web of Science ®Google Scholar
• Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., Conrad, C., Gentry, J., Khudyakov, Y., Waterhouse, D., Owen, S. M., Chapman, E., Roseberry, J. C., McCants, V., Weidle, P. J., … Duwve, J. M. (2016). HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. New England Journal of Medicine, 375(3), 229–239. https://doi.org/10.1056/NEJMoa1515195
   PubMed Web of Science ®Google Scholar
• Pinto, R. M., Berringer, K. R., Melendez, R., & Mmeje, O. (2018). Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS and Behavior, 22(11), 3681–3691. https://doi.org/10.1007/s10461-018-2184-4
   PubMed Web of Science ®Google Scholar
• Pinto, R. M., Lacombe-Duncan, A., Kay, E. S., & Berringer, K. R. (2019). Expanding knowledge about implementation of pre-exposure prophylaxis (PrEP): A methodological review. AIDS and Behavior, 23(10), 2761–2778. https://doi.org/10.1007/s10461-019-02577-7
   PubMed Web of Science ®Google Scholar
• Rondinelli, A. J., Ouellet, L. J., Strathdee, S. A., Latka, M. H., Hudson, S. M., Hagan, H., & Garfein, R. S. (2009). Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug and Alcohol Dependence, 104(1–2), 167–174. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2009.05.013
   PubMed Web of Science ®Google Scholar
• Ross, C. E., & Wu, C-l. (1995). The links between education and health. American Sociological Review, 60(5), 719–745. https://doi.org/10.2307/2096319
   Web of Science ®Google Scholar
• Roth, A., Tran, N., Piecara, B., Welles, S., Shinefeld, J., & Brady, K. (2018). Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: National HIV Behavioral Surveillance, 2015. AIDS and Behavior, 45(4), 1–8.
   Google Scholar
• Roth, A. M., Aumaier, B. L., Felsher, M. A., Welles, S. L., Martinez-Donate, A. P., Chavis, M., & Van Der Pol, B. (2018). An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users. Sexually Transmitted Diseases, 45(4), 217–221.
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Goldshear, J. L., Martinez-Donate, A. P., Welles, S., Chavis, M., & Van Der Pol, B. (2016). Reducing missed opportunities: Pairing sexually transmitted infection screening with syringe exchange services. Sexually Transmitted Diseases, 43(11), 706–708. https://doi.org/10.1097/OLQ.0000000000000516
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Tran, N., Felsher, M., Szep, Z., & Krakower, D. (2019). Heterosexual men anticipate risk compensatory behaviors with future PrEP initiation: Findings from an exploratory cross-sectional study. Sexually Transmitted Diseases, 46(10), e97–e100. https://doi.org/10.1097/OLQ.0000000000001012
   PubMed Web of Science ®Google Scholar
• Sherman, S. G., Schneider, K. E., Park, J. N., Allen, S. T., Hunt, D., Chaulk, C. P., & Weir, B. W. (2019). PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Dependence, 195, 148–155. https://doi.org/10.1016/j.drugalcdep.2018.08.014
   PubMed Web of Science ®Google Scholar
• Shrestha, R., Altice, F. L., Karki, P., & Copenhaver, M. M. (2018). Integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and reduce HIV risk in people who use drugs: A pilot feasibility study. AIDS and Behavior, 22(8), 2640–2649. https://doi.org/10.1007/s10461-018-2099-0
   PubMed Web of Science ®Google Scholar
• Shrestha, R., & Copenhaver, M. (2018). Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment. Frontiers in Public Health, 6, 195. https://doi.org/10.3389/fpubh.2018.00195
   PubMed Web of Science ®Google Scholar
• Shrestha, R., Karki, P., Altice, F. L., Huedo-Medina, T. B., Meyer, J. P., Madden, L., & Copenhaver, M. (2017). Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug-and sex-related behaviors among high-risk drug users on methadone treatment. Drug and Alcohol Dependence, 173, 107–116. https://doi.org/10.1016/j.drugalcdep.2016.12.023
   PubMed Web of Science ®Google Scholar
• Smith, D., Grant, R., Weidle, P., Lansky, A., Mermin, J., & Fenton, K. (2011). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morbidity and Mortality Weekly Report, 60(3), 65–68.
   PubMedGoogle Scholar
• Smith, D. K., Martin, M., Lansky, A., Mermin, J., & Choopanya, K. (2013). Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. MMWR. Morbidity and Mortality Weekly Report, 62(23), 463.
   PubMed Web of Science ®Google Scholar
• Smith, D. K., Thigpen, M. C., Nesheim, S. R., Lampe, M., Paxton, L., & Samandari, T. (2012). Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morbidity and Mortality Weekly Report, 61(31), 586–589.
   PubMedGoogle Scholar
• Sophus, A. I., & Mitchell, J. W. (2018). A review of approaches used to increase awareness of pre-exposure prophylaxis (PrEP) in the United States. AIDS and Behavior, 23(7), 1–22.
   Web of Science ®Google Scholar
• Stein, M., Thurmond, P., & Bailey, G. (2014). Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS and Behavior, 18(9), 1694–1700. https://doi.org/10.1007/s10461-014-0778-z
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80(4 Suppl 3), iii7–iii14. https://doi.org/10.1093/jurban/jtg078
   PubMed Web of Science ®Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L. I., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., Sukalac, T., Thomas, V. T., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. https://doi.org/10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar
• Traeger, M. W., Cornelisse, V. J., Asselin, J., Price, B., Roth, N. J., Willcox, J., Tee, B. K., Fairley, C. K., Chang, C. C., Armishaw, J., Vujovic, O., Penn, M., Cundill, P., Forgan-Smith, G., Gall, J., Pickett, C., Lal, L., Mak, A., Spelman, T. D., … PrEPX Study Team. (2019). Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. JAMA, 321(14), 1380–1390. https://doi.org/10.1001/jama.2019.2947
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. (2012). FDA approves first drug for reducing the risk of sexually acquired HIV infection. https://aidsinfo.nih.gov/news/1254/fda-approves-first-drug-for-reducing-the-risk-of-sexually-acquired-hiv-infection#:∼:text=Today%2C%20the%20U.S.%20Food%20and,activity%20with%20HIV%2Dinfected%20partners
   Google Scholar
• Walters, S. M., Braksmajer, A., Coston, B., Yoon, I., Grov, C., Downing, M. J., Teran, R., & Hirshfield, S. (2020). A syndemic model of exchange sex among HIV-positive men who have sex with men. Archives of Sexual Behavior, 49(6), 1965–1978. https://doi.org/10.1007/s10508-020-01628-8
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Coston, B., Neaigus, A., Rivera, A. V., Starbuck, L., Ramirez, V., Reilly, K. H., & Braunstein, S. L. (2020). The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. The International Journal on Drug Policy, 77, 102671. https://doi.org/10.1016/j.drugpo.2020.102671
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Reilly, K. H., Neaigus, A., & Braunstein, S. (2017). Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: The importance of networks and syringe exchange programs for HIV prevention. Harm Reduction Journal, 14(1), 40. https://doi.org/10.1186/s12954-017-0166-x
   PubMedGoogle Scholar
• Walters, S. M., Rivera, A. V., Reilly, K. H., Anderson, B. J., Bolden, B., Wogayehu, A., Neaigus, A., & Braunstein, S. (2018). Exchange sex among persons who inject drugs in the New York metropolitan area: The importance of local context, gender and sexual identity. AIDS and Behavior, 22(9), 2773–2787. https://doi.org/10.1007/s10461-018-2039-z
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Rivera, A. V., Starbuck, L., Reilly, K. H., Boldon, N., Anderson, B. J., & Braunstein, S. (2017). Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for HIV in New York State: New York City and Long Island, NY, 2011. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75(2013), S383–S391. https://doi.org/10.1097/QAI.0000000000001415
   PubMedGoogle Scholar
• Watters, J. K., & Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems, 36(4), 416–430. https://doi.org/10.2307/800824
   Web of Science ®Google Scholar
• Watters, J. K., Bluthenthal, R. N., & Kral, A. H. (1995). HIV seroprevalence in injection drug users. JAMA, 273(15), 1178–1178.
   PubMed Web of Science ®Google Scholar
• Williams, J. E., Dangerfield, D. T., Kral, A. H., Wenger, L. D., & Bluthenthal, R. N. (2018). Correlates of sexual coercion among people who inject drugs (PWID) in Los Angeles and San Francisco, CA. Journal of Urban Health, 96(3), 1–8.
   Web of Science ®Google Scholar
• Young, R. M., Friedman, S. R., Case, P., Asencio, M. W., & Clatts, M. (2000). Women injection drug users who have sex with women exhibit increased HIV infection and risk behaviors. Journal of Drug Issues, 30(3), 499–523. https://doi.org/10.1177/002204260003000302
   Web of Science ®Google Scholar
• Young, R. M., & Meyer, I. H. (2005). The trouble with “MSM” and “WSW”: Erasure of the sexual-minority person in public health discourse. American Journal of Public Health, 95(7), 1144–1149. https://doi.org/10.2105/AJPH.2004.046714
   PubMed Web of Science ®Google Scholar
• Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. American Journal of Public Health, 108(2), 175–181. https://doi.org/10.2105/AJPH.2017.304132
   PubMed Web of Science ®Google Scholar